HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by PRYSOR-JONES, R. A. Articles by JENKINS, J. S. Search for Related Content PubMed Articles by PRYSOR-JONES, R. A. Articles by JENKINS, J. S.

The effect of bromocriptine on hormone secretion and the growth of the prolactin- and growth hormone (GH)-secreting rat pituitary tumour of the GH₃ cell line has been compared with that of ergotamine and other ergot alkaloids. Bromocriptine in doses ranging from 1 to 20 mg/kg had no effect on tumour growth or on the excessive secretion of GH by the tumour; prolactin concentrations were reduced only by the highest dosage of the drug. Similarly the tumour was resistant to the administration of ergocryptine, ergocornine and the synthetic ergolines, lergotrile and CH 29–717. In contrast, ergotamine reduced secretion of both GH and prolactin and considerably inhibited the growth of the tumour. Experiments in vitro showed that ergotamine inhibited DNA synthesis of the tumour cells and decreased hormone secretion. It was concluded that ergotamine had a direct inhibitory action on the GH₃ cell tumour which was not mediated through the dopaminergic mechanisms.

This article has been cited by other articles:

				A.-K. Fjeldheim, P. I. Hovring, O.-P. Loseth, P. W. Johansen, J. C Glover, V. Matre, O. K. Olstad, S. Reppe, J. O Gordeladze, S I. Walaas, et al. Thyrotrophin-releasing hormone receptor 1 and prothyrotrophin-releasing hormone mRNA expression in the central nervous system are regulated by suckling in lactating rats Eur. J. Endocrinol., May 1, 2005; 152(5): 791 - 803. [Abstract] [Full Text] [PDF]